There have been 50 recent insider transactions recorded for Harmony Biosciences Holdings, Inc. (HRMY), including 21 buys and 26 sells. Total insider buying was valued at $10.32M and total insider selling at $5.43M.
Notable insiders with recent activity include Ignelzi Troy A., Anastasiou Peter, Kapadia Sandip. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — HRMY
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-02 |
Ignelzi Troy A. |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-04-02 |
Ignelzi Troy A. |
Director |
RSU Award |
17,710 |
$27.74 |
$491.28K |
17,710 |
| 2026-04-02 |
Anastasiou Peter |
Chief Operating Officer |
RSU Award |
212,241 |
$27.74 |
$5.89M |
212,241 |
| 2026-01-26 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
3,746 |
$37.15 |
$139.17K |
24,521 |
| 2026-01-25 |
Dayno Jeffrey M. |
President, CEO |
Tax Withholding of RSU |
5,654 |
$36.82 |
$208.18K |
7,346 |
| 2026-01-25 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
2,553 |
$36.82 |
$94K |
2,172 |
| 2026-01-25 |
Serafin Andrew |
Chief Strategy Officer |
Tax Withholding of RSU |
1,126 |
$36.82 |
$41.46K |
1,474 |
| 2026-01-25 |
Budur Kumar |
Chief Medical Officer |
Tax Withholding of RSU |
1,372 |
$36.82 |
$50.52K |
1,290 |
| 2026-01-24 |
Dayno Jeffrey M. |
President, CEO |
Tax Withholding of RSU |
4,785 |
$36.82 |
$176.18K |
5,715 |
| 2026-01-24 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
2,239 |
$36.82 |
$82.44K |
1,574 |
| 2026-01-24 |
Serafin Andrew |
Chief Strategy Officer |
Tax Withholding of RSU |
1,116 |
$36.82 |
$41.09K |
1,384 |
| 2026-01-24 |
Budur Kumar |
Chief Medical Officer |
Tax Withholding of RSU |
1,153 |
$36.82 |
$42.45K |
1,035 |
| 2026-01-22 |
Dayno Jeffrey M. |
President, CEO |
RSU Award |
52,900 |
- |
- |
52,900 |
| 2026-01-22 |
Kapadia Sandip |
Chief Financial Officer |
RSU Award |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Serafin Andrew |
Chief Strategy Officer |
RSU Award |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Budur Kumar |
Chief Medical Officer |
RSU Award |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Zaeske Adam H. |
Chief Commercial Officer |
RSU Award |
16,200 |
- |
- |
16,200 |
| 2026-01-15 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
20,961 |
$35.92 |
$752.83K |
- |
| 2025-12-12 |
Dayno Jeffrey M. |
President, CEO |
Informative Sell |
5,933 |
$40.11 |
$237.96K |
- |
| 2025-12-05 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
20,000 |
$39.54 |
$790.9K |
- |
| 2025-11-21 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
3,427 |
$35.00 |
$119.95K |
- |
| 2025-09-30 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
24,039 |
$27.56 |
$662.51K |
20,961 |
| 2025-08-28 |
Valor Iv Pharma Holdings, Llc |
10 Percent Owner |
Other (Sell) |
6,618,033 |
- |
- |
- |
| 2025-08-15 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
21,573 |
$36.50 |
$787.38K |
- |
| 2025-05-25 |
Graf R. Mark |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Gracias Antonio J. |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Sender Gary |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Szyper Linda M |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Sabater Juan A. |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Anastasiou Peter |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Philip Ron M |
Director |
RSU Award |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-01 |
Budur Kumar |
Chief Medical Officer |
Tax Withholding of RSU |
8,869 |
$29.86 |
$264.83K |
9,881 |
| 2025-04-07 |
Zaeske Adam H. |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-04-07 |
Zaeske Adam H. |
Chief Commercial Officer |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2025-04-02 |
Philip Ron M |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-04-02 |
Philip Ron M |
Director |
RSU Award |
14,077 |
$32.53 |
$457.92K |
14,077 |
| 2025-04-01 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
740 |
$33.12 |
$24.51K |
- |
| 2025-03-29 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
8,014 |
$33.19 |
$265.98K |
6,986 |
| 2025-03-03 |
Dierks Jeffrey |
Chief Commercial Officer |
Option Exercise (Sell) |
4,869 |
$8.22 |
$40.02K |
- |
| 2025-01-27 |
Kapadia Sandip |
Chief Financial Officer |
Informative Sell |
1,775 |
$38.05 |
$67.55K |
- |
| 2025-01-27 |
Dierks Jeffrey |
Chief Commercial Officer |
Informative Sell |
1,629 |
$38.02 |
$61.94K |
- |
| 2025-01-25 |
Dayno Jeffrey M. |
President, CEO |
RSU Award |
52,000 |
- |
- |
52,000 |
| 2025-01-25 |
Kapadia Sandip |
Chief Financial Officer |
RSU Award |
18,900 |
- |
- |
18,900 |
| 2025-01-25 |
Dierks Jeffrey |
Chief Commercial Officer |
RSU Award |
13,450 |
- |
- |
13,450 |
| 2025-01-25 |
Serafin Andrew |
Chief Strategy Officer |
RSU Award |
10,400 |
- |
- |
10,400 |
| 2025-01-25 |
Budur Kumar |
Chief Medical Officer |
RSU Award |
10,650 |
- |
- |
10,650 |
| 2025-01-24 |
Dayno Jeffrey M. |
President, CEO |
Tax Withholding of RSU |
4,567 |
$38.01 |
$173.59K |
5,933 |
| 2025-01-24 |
Kapadia Sandip |
Chief Financial Officer |
Tax Withholding of RSU |
2,037 |
$38.01 |
$77.43K |
1,775 |
| 2025-01-24 |
Dierks Jeffrey |
Chief Commercial Officer |
Informative Sell |
5,125 |
$37.87 |
$194.1K |
- |
| 2025-01-24 |
Serafin Andrew |
Chief Strategy Officer |
Tax Withholding of RSU |
865 |
$38.01 |
$32.88K |
1,635 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
